Lumosa Therapeutics Co., Ltd. (TPEX: 6535)
Health Care · Pharmaceuticals · TW
NT$81.30
-4.35% today · -71.4% 1Y
Lumosa Therapeutics Co., Ltd. (TPEX: 6535) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $425.85M and employs 36 people.
Over the last twelve months the share price has lost 71.4%, trading between 73.70 and 319.50.
Tweenvest scores Lumosa Therapeutics Co., Ltd. across four factors: quality 42/100, value 53/100, growth 50/100. Its strongest factor is value.
6535 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $425.85M
- Revenue (TTM)
- $1.08M
- P/E
- —
- EPS
- -2.23
- Dividend yield
- —
- Beta (5Y)
- 0.07
- 52-week high
- NT$319.50
- 52-week low
- NT$73.70
- Avg volume (3M)
- —
- Shares outstanding
- 167.49M
- Employees
- 36
- Next earnings
- —
About Lumosa Therapeutics Co., Ltd.
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
- ISIN
- TW0006535008
- Founded
- 2000
- Listed since
- Jul 16, 2015
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Guizhou Yibai Pharmaceutical Co., Ltd.SHSE: 600594 | $430.95M | CN¥3.68 | +1.10% |
| SMS Pharmaceuticals LimitedNSEI: SMSPHARMA | $430.28M | Rs444.65 | -5.65% |
| Anhui Fengyuan Pharmaceutical Co., Ltd.SZSE: 000153 | $427.35M | CN¥6.16 | +0.82% |
| Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim SirketiIBSE: GENIL | $425.91M | TL4.67 | -11.89% |
| Gufic Biosciences LimitedBSE: 509079 | $419.45M | Rs404.80 | -3.20% |
| Renata PLCDSE: RENATA | $418.98M | Tk449.90 | +0.27% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,LtdSHSE: 600671 | $416.71M | CN¥22.92 | +5.19% |
| Chengdu huasun technology group Inc. , LTD.SZSE: 000790 | $413.45M | CN¥4.44 | +0.45% |
Figures last refreshed Oct 11, 2026.